Professor Dr. Robert Schiestl Ph. D. Joins Pacific Software Inc. as Chief Science Advisor (CSA)
22 juil. 2024 18h31 HE | Pacific Software Inc.
Pacific Software Inc. appoints Dr. Robert Schiestl as Chief Science Advisor to enhance their Dermatrix technology and dietary supplements.
BREA Dicey Perrine
Brera Holdings Executes Perfect Set Hiring UCLA Volleyball MVP Dicey Perrine
11 mars 2024 08h05 HE | Brera Holdings PLC
Brera Holdings (Nasdaq: BREA) appoints Dicey Perrine, former UCLA Volleyball MVP, as the Head of its US Operations
JLab announces college sports sponsorships
JLab Kicks Off College Sports Program to Champion Student Athlete Success
22 févr. 2024 09h01 HE | JLab Audio
San Diego, CA, Feb. 22, 2024 (GLOBE NEWSWIRE) -- JLab today announced a comprehensive college sports program that will support 17 D1 schools along with student athletes across men’s and women’s...
Figure 1
National Institute of Health to Fund Preclinical Development of Trethera Lead Drug, TRE-515, for Treatment of Crohn’s Disease
25 sept. 2023 11h22 HE | Trethera Corporation
LOS ANGELES, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Trethera Corporation, a clinical stage biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism for the treatment...
Figure 1: Representative stained spinal cord sections from a mouse ADEM model. Arrows point to regions of leukocyte infiltration
Trethera Receives NIH Grant for Preclinical Development in the Pediatric Neurologic Disease Acute Disseminated Encephalomyelitis
14 août 2023 11h23 HE | Trethera Corporation
LOS ANGELES, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Trethera Corporation, a clinical stage biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism for the treatment...
PET scan images showing presence of target enzyme dCK in normal mice (row A), and lupus diseased mice (row B).
Trethera Receives Grant from National Institute of Allergy and Infectious Diseases for the Advancement of TRE-515 in Lupus
27 juin 2023 11h14 HE | Trethera Corporation
LOS ANGELES, June 27, 2023 (GLOBE NEWSWIRE) -- Trethera Corporation, a clinical stage biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism for the treatment...
Company LOGO 1 (1).jpg
NewHydrogen Promotes Steven Hill to Chief Executive Officer
16 juin 2023 03h30 HE | NewHydrogen, Inc.
SANTA CLARITA, Calif., June 16, 2023 (GLOBE NEWSWIRE) -- NewHydrogen, Inc. (OTC:NEWH), the developer of a breakthrough technology to produce low-cost green hydrogen, today announced that Steven Hill...
PharmAla Biotech Logo 800 x 422.png
USFDA Approves LaNeo MDMA for Clinical Trial Use in the United States
09 juin 2023 15h48 HE | PharmAla Biotech
Approved Study to Examine Tolerability of MDMA in Schizophrenia at UCLA VANCOUVER, British Columbia, June 09, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE:...
Figure 1
Trethera Receives $2 Million National Cancer Institute Grant for Advancement of Clinically Relevant Biomarkers in Phase 1 Trial
30 mai 2023 12h16 HE | Trethera Corporation
LOS ANGELES, May 30, 2023 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism for...
HOK Logo.JPG
HOK Signals its Investment in Downtown Los Angeles with Studio Relocation to the Arts District
27 avr. 2023 11h00 HE | HOK
LOS ANGELES, April 27, 2023 (GLOBE NEWSWIRE) -- In a move that reflects its bold, creative and forward-thinking culture, HOK’s Los Angeles studio has chosen to relocate its award-winning Southern...